2014
DOI: 10.1093/ndt/gfu240
|View full text |Cite
|
Sign up to set email alerts
|

Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway

Abstract: These findings indicate that tamoxifen has a beneficial effect on UUO-induced tubulointerstitial fibrosis by suppression of renal fibroblast activation via modulation of ERα-mediated renal TGF-β1/Smad signaling pathway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
72
0
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(84 citation statements)
references
References 41 publications
9
72
0
3
Order By: Relevance
“…Among these, the expressions of fibronectin and TGF-␤1 are upregulated in the UUO model of obstructive nephropathy and may aid the progression to tubulointerstitial fibrosis (12,25,31,34,37,55,66,68). Understanding the regulatory pathways that control their production may be paramount to developing effective therapeutics to treat these diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Among these, the expressions of fibronectin and TGF-␤1 are upregulated in the UUO model of obstructive nephropathy and may aid the progression to tubulointerstitial fibrosis (12,25,31,34,37,55,66,68). Understanding the regulatory pathways that control their production may be paramount to developing effective therapeutics to treat these diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Transforming growth factor (TGF)-β is an important cytokine regulating apoptosis, cell cycle, differentiation and extracellular matrix accumulation (31)(32)(33). A large body of evidence has linked TGF-β/ Smad signaling to the development and progression of renal fibrosis (34)(35)(36).…”
Section: Sirt1 Reduces Fibrosis By Smad3 (Targeting Mothers Against Dmentioning
confidence: 99%
“…Estos modelos sugieren que el TGF-β no tiene un papel crítico en la inmunidad de los ratones. Sin embargo, esta conclusión hay que tomarla con precaución pues, entre otras alteraciones, el tratamiento con dosis de tamoxifeno similares a las que se usan para la eliminación genética del TGF-βRII pueden tener efectos colaterales (Kim, et al, 2014). Considerando toda la evidencia disponible, podemos decir que en ninguno modelo se ha establecido claramente un rol inmunomodulador importante del TGF-β en una infección viral in vivo.…”
Section: Cd4dntgf-briiunclassified